Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $1,012 | 5 | 50.8% |
| Food and Beverage | $981.31 | 13 | 49.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | $1,471 | 13 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $243.86 | 2 | $0 (2022) |
| Takeda Pharmaceuticals U.S.A., Inc. | $124.83 | 1 | $0 (2024) |
| Aurinia Pharma U.S., Inc. | $121.82 | 1 | $0 (2022) |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $31.09 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,596 | 14 | Bayer Healthcare Pharmaceuticals Inc. ($1,471) |
| 2022 | $243.64 | 2 | Alexion Pharmaceuticals, Inc. ($121.82) |
| 2020 | $31.09 | 1 | Otsuka Pharmaceutical Development & Commercialization, Inc. ($31.09) |
| 2019 | $122.04 | 1 | Alexion Pharmaceuticals, Inc. ($122.04) |
All Payment Transactions
18 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/27/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $88.66 | General |
| Category: Cardio-renal | ||||||
| 02/27/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $82.08 | General |
| Category: Cardio-renal | ||||||
| 02/27/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Travel and Lodging | In-kind items and services | $74.57 | General |
| Category: Cardio-renal | ||||||
| 02/27/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $69.56 | General |
| Category: Cardio-renal | ||||||
| 02/27/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Travel and Lodging | In-kind items and services | $62.11 | General |
| Category: Cardio-renal | ||||||
| 02/27/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $34.10 | General |
| Category: Cardio-renal | ||||||
| 02/27/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $34.10 | General |
| Category: Cardio-renal | ||||||
| 02/27/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $34.10 | General |
| Category: Cardio-renal | ||||||
| 02/26/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Travel and Lodging | In-kind items and services | $472.80 | General |
| Category: Cardio-renal | ||||||
| 02/26/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Travel and Lodging | In-kind items and services | $306.54 | General |
| Category: Cardio-renal | ||||||
| 02/26/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $102.30 | General |
| Category: Cardio-renal | ||||||
| 02/26/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Travel and Lodging | In-kind items and services | $95.55 | General |
| Category: Cardio-renal | ||||||
| 02/26/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.81 | General |
| Category: Cardio-renal | ||||||
| 02/15/2024 | Takeda Pharmaceuticals U.S.A., Inc. | LIVTENCITY (Drug) | Food and Beverage | In-kind items and services | $124.83 | General |
| Category: IMMUNOLOGY | ||||||
| 10/26/2022 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $121.82 | General |
| Category: Rare Disease | ||||||
| 10/26/2022 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $121.82 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 02/07/2020 | Otsuka Pharmaceutical Development & Commercialization, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $31.09 | General |
| Category: NEPHROLOGY | ||||||
| 11/19/2019 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Drug) | Food and Beverage | In-kind items and services | $122.04 | General |
| Category: Immunology | ||||||
About Dr. Ruby Patel, MD
Dr. Ruby Patel, MD is a Pediatrics healthcare provider based in Palo Alto, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/24/2015. The National Provider Identifier (NPI) number assigned to this provider is 1275927691.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ruby Patel, MD has received a total of $1,993 in payments from pharmaceutical and medical device companies, with $1,596 received in 2024. These payments were reported across 18 transactions from 5 companies. The most common payment nature is "Travel and Lodging" ($1,012).
Practice Information
- Specialty Pediatrics
- Other Specialties Pediatric Nephrology
- Location Palo Alto, CA
- Active Since 03/24/2015
- Last Updated 04/16/2024
- Taxonomy Code 208000000X
- Entity Type Individual
- NPI Number 1275927691
Products in Payments
- Kerendia (Drug) $1,471
- LIVTENCITY (Drug) $124.83
- ULTOMIRIS (Drug) $122.04
- LUPKYNIS (Drug) $121.82
- ULTOMIRIS (Biological) $121.82
- JYNARQUE (Drug) $31.09
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatrics Doctors in Palo Alto
Carlos Milla, Md, MD
Pediatrics — Payments: $135,086
Paul Grimm, Md, MD
Pediatrics — Payments: $115,205
Janene Fuerch, Md, MD
Pediatrics — Payments: $106,632
Jennifer Frankovich, Md, MD
Pediatrics — Payments: $99,067
Crystal Mackall, Md, MD
Pediatrics — Payments: $56,852
Jennifer O'malley, Md, Phd, MD, PHD
Pediatrics — Payments: $46,160